Higa M

References (3)

Title : Partial Response to Nivolumab and Ipilimumab in a Patient With Malignant Pleural Mesothelioma and Pre-Existing Myasthenia Gravis Without Severe Flares or Immune-Related Adverse Events: A Case Report - Higa_2025_Respirol.Case.Rep_13_e70297
Author(s) : Higa M , Kuda T , Ohya Y , Kawasaki H
Ref : Respirol Case Rep , 13 :e70297 , 2025
Abstract :
PubMedSearch : Higa_2025_Respirol.Case.Rep_13_e70297
PubMedID: 40842502

Title : Partial Response to Nivolumab and Ipilimumab in a Patient With Malignant Pleural Mesothelioma and Pre-Existing Myasthenia Gravis Without Severe Flares or Immune-Related Adverse Events: A Case Report - Higa_2025_Respirol.Case.Rep_13_e70297
Author(s) : Higa M , Kuda T , Ohya Y , Kawasaki H
Ref : Respirol Case Rep , 13 :e70297 , 2025
Abstract :
PubMedSearch : Higa_2025_Respirol.Case.Rep_13_e70297
PubMedID: 40842502

Title : Partial Response to Nivolumab and Ipilimumab in a Patient With Malignant Pleural Mesothelioma and Pre-Existing Myasthenia Gravis Without Severe Flares or Immune-Related Adverse Events: A Case Report - Higa_2025_Respirol.Case.Rep_13_e70297
Author(s) : Higa M , Kuda T , Ohya Y , Kawasaki H
Ref : Respirol Case Rep , 13 :e70297 , 2025
Abstract :
PubMedSearch : Higa_2025_Respirol.Case.Rep_13_e70297
PubMedID: 40842502